UK clinical trials - updated daily from ClinicalTrials.gov
TrialConnect
Mental Health

Depression & Treatment-Resistant Depression Clinical Trials in the UK

Find clinical trials for depression in the United Kingdom. Explore treatment pathways including medications, psychotherapy, and novel therapies like psilocybin and ketamine.

Understanding Depression

Depression affects ~1 in 6 people in the UK at some point in their lives. It goes beyond normal sadness - causing persistent low mood, loss of interest, sleep problems, fatigue, and difficulty concentrating. Most people respond to treatment, but ~30% have treatment-resistant depression (failure of 2+ antidepressants). Depression is the leading cause of disability worldwide.

Treatment Pathway

Step 1: Psychological therapy (CBT, counselling) for mild depression. Step 2: SSRI antidepressant (sertraline, fluoxetine, citalopram) ± therapy. Step 3: Switch antidepressant or add (mirtazapine augmentation, SNRIs). Step 4: For treatment-resistant depression: esketamine nasal spray (Spravato) with oral antidepressant, lithium augmentation, or atypical antipsychotic augmentation (aripiprazole, quetiapine). For severe treatment-resistant cases: electroconvulsive therapy (ECT) remains highly effective.

Emerging Therapies

Exciting new approaches: psilocybin-assisted therapy (Phase 2/3 trials showing rapid, sustained antidepressant effects), ketamine/esketamine (already approved for TRD), neuromodulation (TMS - transcranial magnetic stimulation, now available on NHS for TRD), digital therapeutics (NHS-approved apps for depression), and precision psychiatry (matching patients to treatments based on genetic/biomarker profiles).

Clinical Trial Opportunities

The UK is a global leader in depression research. Active trials include: psilocybin therapy (COMPASS Pathways, Imperial College), novel rapid-acting antidepressants, digital CBT and AI-guided therapy, anti-inflammatory agents for depression, gut-brain axis interventions, psychedelic-assisted therapy, and brain stimulation personalisation. The NHS Improving Access to Psychological Therapies (IAPT) programme supports research integration.

Related Conditions

Ready to find your trial?

Free AI-powered matching - no signup required

Search major depressive disorder Trials →